Search Results - "KAWAGUCHI, YOSHINDO"

Refine Results
  1. 1

    A novel treatment of hyperinsulinemic hypoglycemia induced by insulin antibodies with alkali administration: a case report by Kobayashi, Seiji, Amano, Houichi, Kawaguchi, Yoshindo, Yokoo, Takashi

    Published in Journal of medical case reports (11-03-2019)
    “…Insulin autoimmune syndrome is a rare cause of hyperinsulinemic hypoglycemia characterized by autoantibodies to human insulin without previous insulin use. We…”
    Get full text
    Journal Article
  2. 2

    Spot urine protein/creatinine ratio as a reliable estimate of 24-hour proteinuria in patients with immunoglobulin A nephropathy, but not membranous nephropathy by Kobayashi, Seiji, Amano, Hoichi, Terawaki, Hiroyuki, Ogura, Makoto, Kawaguchi, Yoshindo, Yokoo, Takashi

    Published in BMC nephrology (06-08-2019)
    “…Proteinuria is known to be associated with both kidney function deterioration and cardiovascular diseases. While proteinuria estimation from 24-h urine samples…”
    Get full text
    Journal Article
  3. 3

    Encapsulating peritoneal sclerosis in Japan: A prospective, controlled, multicenter study by Kawanishi, Hideki, Kawaguchi, Yoshindo, Fukui, Hiroyoshi, Hara, Shigeko, Imada, Akio, Kubo, Hitoshi, Kin, Masao, Nakamoto, Masahiko, Ohira, Seiji, Shoji, Takao

    Published in American journal of kidney diseases (01-10-2004)
    “…Background: Encapsulating peritoneal sclerosis (EPS) is recognized as a rare but serious complication of peritoneal dialysis (PD). The aim of this study was to…”
    Get full text
    Journal Article
  4. 4
  5. 5
  6. 6
  7. 7

    A new peritoneal dialysis fluid for Japanese patients: a randomized non-inferiority clinical trial of safety and efficacy by Nakayama, Masaaki, Kawaguchi, Yoshindo, Akiba, Takashi, Kim, Masao, Naito, Hidemune, Hara, Shigeko, Maeba, Teruhiko, Yorioka, Noriaki, Sloand, James A., Marshall, Mark R.

    Published in Clinical and experimental nephrology (01-10-2017)
    “…Background We report here two new peritoneal dialysis fluids (PDFs) for Japan [BLR 250, BLR 350 (Baxter Limited, Japan)]. The PDFs use two-chamber systems, and…”
    Get full text
    Journal Article
  8. 8

    Recommendations on the management of encapsulating peritoneal sclerosis in Japan, 2005 : Diagnosis, predictive markers, treatment, and preventive measures by KAWAGUCHI, Yoshindo, SAITO, Akira, KAWANISHI, Hideki, NAKAYAMA, Masaaki, MIYAZAKI, Masanobu, NAKAMOTO, Hidetomo, TRANAEUS, Anders

    Published in Peritoneal dialysis international (01-04-2005)
    “…This comprehensive update on the management of encapsulating peritoneal sclerosis incorporates insights gained from recently published findings and the…”
    Get full text
    Journal Article
  9. 9
  10. 10
  11. 11

    IS TECHNIQUE SURVIVAL ON PERITONEAL DIALYSIS BETTER IN JAPAN? by Nakamoto, Hidetomo, Kawaguchi, Yoshindo, Suzuki, Hiromichi

    Published in Peritoneal dialysis international (01-03-2006)
    “…Department of Nephrology, 1 Saitama Medical School, Saitama; Department of Nephrology, 2 Kanagawa Prefectural Hospital, Japan Correspondence to: H. Nakamoto,…”
    Get full text
    Journal Article
  12. 12
  13. 13

    Risk factors for encapsulating peritoneal sclerosis in patients who have experienced peritoneal dialysis treatment by Yamamoto, Ryo, Otsuka, Yasushi, Nakayama, Masaaki, Maruyama, Yukio, Katoh, Naohiko, Ikeda, Masato, Yamamoto, Hiroyasu, Yokoyama, Keitaro, Kawaguchi, Yoshindo, Matsushima, Masato

    Published in Clinical and experimental nephrology (01-06-2005)
    “…The present study was conducted to clarify the clinical risk factors related to the development of encapsulating peritoneal sclerosis (EPS), which is one of…”
    Get full text
    Journal Article
  14. 14

    Reversal of anemia by erythropoietin therapy retards the progression of chronic renal failure, especially in nondiabetic patients by Kuriyama, S, Tomonari, H, Yoshida, H, Hashimoto, T, Kawaguchi, Y, Sakai, O

    Published in Nephron (2015) (1997)
    “…Therapy with human recombinant erythropoietin (EPO) has been accepted as effective for renal anemia in dialysis patients. However, studies in rats have shown…”
    Get more information
    Journal Article
  15. 15

    Sclerosing encapsulating peritonitis in patients undergoing continuous ambulatory peritoneal dialysis: a report of the Japanese Sclerosing Encapsulating Peritonitis Study Group by Nomoto, Y, Kawaguchi, Y, Kubo, H, Hirano, H, Sakai, S, Kurokawa, K

    Published in American journal of kidney diseases (01-09-1996)
    “…Patients undergoing continuous ambulatory peritoneal dialysis (CAPD) who developed sclerosing encapsulating peritonitis (SEP) were retrospectively studied in…”
    Get more information
    Journal Article
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20